Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.3
2.28
NAV
₹30.64
₹276.12
Fund Started
20 Jun 2019
01 Aug 2005
Fund Size
₹854.04 Cr
₹1106.71 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
8.42%
7.29%
3 Year
23.93%
25.21%
5 Year
14.48%
15.30%
Equity
98.45%
98.21%
Cash
1.55%
1.79%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.34% |
Apollo Hospitals Enterprise Ltd. | 7.78% |
Torrent Pharmaceuticals Ltd. | 5.20% |
JB Chemicals & Pharmaceuticals Ltd. | 4.99% |
Ajanta Pharma Ltd. | 4.53% |
Lupin Ltd. | 4.21% |
Fortis Healthcare Ltd. | 4.17% |
Aurobindo Pharma Ltd. | 4.16% |
Abbott India Ltd. | 4.02% |
Ipca Laboratories Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 9.42% |
Ajanta Pharma Ltd. | 7.04% |
Lupin Ltd. | 5.79% |
Glenmark Pharmaceuticals Ltd. | 4.25% |
Apollo Hospitals Enterprise Ltd. | 3.75% |
Gland Pharma Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.52% |
Dr. Reddy's Laboratories Ltd. | 3.48% |
Alkem Laboratories Ltd. | 3.47% |
Fortis Healthcare Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
20 Jun 2019
01 Aug 2005
